Mira Launches Ovum Wand to Predict Menopause and Monitor Fertility Status for Women Over...
SAN RAMON, Calif. - August 2, 2022 - (Newswire.com)
The FDA has listed Mira's new Mira Ovum Wand as an over-the-counter tool to detect the follicle-stimulating hormone (FSH) in urine. Starting October 2022, the product will be available to U.S. customers. The wands help monitor FSH levels to predict approaching menopause. They can also be used to monitor fertility and find possible causes of reproductive issues for women after 35.
Menopause has been a taboo subject for many generations. The lack of relevant education results in numerous misconceptions about this time in women's lives. Studies show that to this date, one-third of women do not research the topic before they experience menopause. A survey of 1,039 American women ages 40-65 finds that 45% of them didn't know the distinction between perimenopause and menopause. The Mira Ovum Wand can provide information to help understand perimenopause, predict menopause and address the symptoms early. FSH tracking can also help track the effectiveness of hormone replacement therapy to make it more targeted and personalized.
Tracking the follicle-stimulating hormone is essential for women in their 20s, 30s, or 40s because it directly impacts their ability to get pregnant. To predict approaching menopause or track changes in fertility, a person needs to test over several days for two or more cycles. Mira allows users to safely and regularly monitor their FSH levels at home without the need for constant and painful blood tests. And unlike FSH test strips, Mira provides lab-accurate numbers and data points that are saved and analyzed to give users personalized health insights. Users can also choose to share this data with their medical provider.
"The Mira Ovum Wand further expands our capabilities in at-home hormone testing. We can now provide accurate lab-like results for LH, E3G, PdG, and FSH. The launch reinforces Mira's goal to support women throughout their lives by helping them understand their hormones at any age, be it puberty, adulthood, or later years. This knowledge grants the ability to make informed fertility decisions and eliminates the dread associated with the word "menopause." So, women can go through this journey with confidence and awareness," says Sylvia Kang, CEO of Mira.
Mira offers a whole line of hormone test wands, including Mira Fertility (luteinizing hormone), Mira Fertility Plus (estrone-3-glucuronide and luteinizing hormone) and Mira Confirm (pregnanediol glucuronide). Like its predecessors, the new Mira Ovum Wand is compatible with the Mira Analyzer. This high-precision testing device uses machine learning to track changing hormone patterns over time, making Mira more effective than regular ovulation strips. The analyzer can be connected to Mira App to display clear numerical data along with personalized insights on the user's reproductive health.
ABOUT MIRA
Mira is the first at-home test to offer a personalized and lab-quality tracking system for monitoring women's reproductive health. It uses patented AI algorithms to accurately measure the levels of major hormones in a woman's urine to provide a holistic view of a woman's reproductive health. Mira is FDA-listed, clinically approved, and OB-GYN recommended.
For more information on Mira, please visit miracare.com.
Press contact: | [email protected] |
Press Release Service by Newswire.com
Original Source: Mira Launches Ovum Wand to Predict Menopause and Monitor Fertility Status for Women Over 35
RISE Healthcare Group Expands Free Trial of HAL Wearable Medical Device
Affordable Medication Available to USA Consumers From MedsEngage Online Pharmacy
MeituEve Teams Up With Scientists From Chinese Academy of Sciences to Find Key Genes...
Tribun Health Releases a New Version of the Next-Generation Telepathology Solution for Remote Case...
Tribun Health Appoints Ludovic d’Apréa as Chief Customer Officer and Strengthens Its C-Level Global...
PARIS, May 25, 2022 (Newswire.com) - Tribun Health today announced the appointment of Ludovic d'Apréa as Chief Customer Officer (CCO) of the Company, in charge of global sales and operations, including projects implementation and customer care. Ludovic has a proven track record as a global leader of motivating and developing strong teams while driving complex change, putting a strong set of operational processes in place and achieving growth & turnaround in the business, all within highly competitive industries such as healthcare IT and medical imaging equipment.
Prior to joining Tribun Health, Ludovic led the Enterprise Diagnostic Informatics business of Philips Healthcare. He joined the Company as part of the acquisition of the Healthcare Information Solutions division (PACS) of Carestream by Philips. Ludovic has been leading that business unit for seven years from Rochester, NY, USA. He previously ran the Business of Carestream in Europe after the General Electric's Healthcare IT business for France, Belgium and Luxembourg. His extensive experience and expertise offer a promising perspective for further achievement as a Chief Customer Officer overseeing Tribun Health's global sales and services to move forward a worldwide standard of quality.
"With the strong growth ahead in digital pathology, it became evident that we needed to find someone who could accelerate our business development across the world with first-class project delivery and customer care. We were looking for someone with cross-team communication and strategic planning as well as rigorous execution. It was obvious Ludovic was the right man, and I am so glad to have him on board," says Jean-François Pomerol, CEO at Tribun Health.
"I am thrilled to have joined Tribun Health as Executive Director and also shareholder. With an intimate pathology understanding, deep customer relationships, and innovative solutions powered by in-house AI capability, Tribun Health is an opportunity for me to bring my experience to a company that has a lot of growth potential. There are still many things to implement, which notably includes strengthening our teams across the globe with new talents. It is an honor to join that team at this extraordinary time," says Ludovic d'Apréa, New Chief Customer Officer at Tribun Health.
About Tribun Health: Tribun Health empowers confident decisions. The Paris-based, privately held company addresses a significant, fast-growing, and unmet need for expert end-to-end pathology departmental digitalization. Tribun Health is a pioneer in digital pathology workflow solutions with image acquisition (Macro), image storage/organization, web-based image management system (IMS), image analysis using AI-powered deep and machine learning algorithms, remote case sharing with peer review and report generation. Tribun Health's award-winning core platform, CaloPix, is considered the industry leader, winning the Best in Klas 2022 award for the most successful digital pathology provider in Europe. Tribun Health's extensive, decade-long expertise drives confidence for laboratories looking for a seamless transition to a digital pathology suite. https://www.tribun.health/
Original Source: Tribun Health Appoints Ludovic d'Apréa as Chief Customer Officer and Strengthens Its C-Level Global Team
Tribun Health is Entering the Pharmaceutical and Drug Development Market to Meet the Challenges...
Enlyt Health Joins Epic’s App Orchard
Enlyt Health, the leading Low Code Mobile Platform as a Service for Healthcare, announced that it has partnered with Epic to offer its platform on the App Market.
"We're delighted to join an amazing Marketplace and offer easy access to Enlyt Health Platform," said Scott Fielder, Enlyt Health's Founder and Chief Executive Officer. "Giving Health Systems the opportunity to expand on their Digital Front Door footprint and utilize the amazing power that Epic currently provides is a huge win for all sides. By joining the App Market, we're able to bring enhanced patient experience directly to Epic patients in a clean and simplified way, making it easier for patients to make informed care decisions in real-time."
The Enlyt Health platform has been recognized by healthcare systems for its innovation in the Digital Front Door experience and improving patient experience. All Epic community members can now explore and access Enlyt Health platform in the App Market.
About Enlyt Health
Enlyt Health helps organizations build Digital Front Doors faster by providing a Low Code Mobile Platform that breaks down silos, provides brand recognition, removes disjointed end-user frustration and enhances patient experience all in one future innovation-focused platform. Customers can deploy their Digital Front Door mobile application in as little as 90 days delivering exponentially higher ROI than ground-up builds, the comfort of knowing their applications are built on an industry-proven platform and know their patients are getting industry-leading patient engagement. Learn more at www.enlythealth.com.
Contact Information:
Ryan Blachly
[email protected]
631-332-0400
Press Release Service by Newswire.com
Original Source: Enlyt Health Joins Epic's App Orchard
Tribun Health Launches New AI Computational Pathology Solution for Diagnostics, Prognosis and Drug Development
